Testing Video Information About Mammography Screening

NCT ID: NCT04424758

Last Updated: 2020-07-15

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

400 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-06-16

Study Completion Date

2020-07-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study examines how video information about mammography screening effect participants knowledge opinions and choice about screening.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study will be conducted as a single site parallel-arm, 1:1 randomized controlled trial (RCT) through a web-based quantitative survey uploaded in online forums. Participants will be randomized to either the intervention group (video information about mammography screening followed by a survey about mammography screening) or the control group (video information about energy systems followed by the same survey). The survey computer programme will randomly assign each respondent to either the intervention arm or the control arm in the beginning of the survey.

The allocation will be concealed from the researchers. The survey computer programme will deliver the intervention right after randomization. Participants will be aware of the allocation. However, they do not know about the study design. Data analysts will be kept blinded to the allocation.

Choice, knowledge and opinions related to mammography screening will be compared between the control group and the intervention group at one timepoint.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Breast Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

See protocol
Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

DOUBLE

Investigators Outcome Assessors
See protocol

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Intervention group

Receives information about mammography screening through a video. The video was developed with the goal of informing about mammography screening in a societal perspective using best available evidence.

Group Type EXPERIMENTAL

Video information about mammography screening

Intervention Type OTHER

A video informing about mammography screening

Control group

Receives information about energy systems through a video. The video does not contain any information related to mammography screening.

Group Type PLACEBO_COMPARATOR

Video information about smart energy systems

Intervention Type OTHER

A video informing about smart energy systems

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Video information about mammography screening

A video informing about mammography screening

Intervention Type OTHER

Video information about smart energy systems

A video informing about smart energy systems

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Participants eligible for the study includes all men and women age 18-75.

Exclusion Criteria

* None
Minimum Eligible Age

18 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Copenhagen

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Manja Dahl Jensen

Principal investigator, Medical doctor, PhD-student

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Manja Jensen, MD

Role: PRINCIPAL_INVESTIGATOR

Section of General Practice, University of Copenhagen

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Copenhagen, Section of General Practice

Copenhagen, Capital, Denmark

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Denmark

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Manja Jensen, MD

Role: CONTACT

0045-35333123

John Brodersen, MD, PhD

Role: CONTACT

0045-35333123

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Manja D Jensen, MD

Role: primary

0045-35333123

John Brodersen, MD, phd

Role: backup

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol and Statistical Analysis Plan

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2204MDJ

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Study of Monochromatic X-ray Mammography System
NCT07219797 NOT_YET_RECRUITING NA
Lymphedema Screening
NCT04606511 UNKNOWN NA